S-1: Mitesco S-1: Debt Restructuring, New Tech Focus, & Going Concern

Mitesco, Inc. files an S-1 registration for the resale of over 106 million common shares, highlighting a strategic pivot to data center and AI services following the closure of its unprofitable clinic operations, amidst significant debt restructuring and ongoing going concern doubts.

Summary

• Mitesco, Inc. (MITI) is registering up to 106,836,091 shares of common stock for resale by selling stockholders, from which the company will not receive any proceeds.
• The company has transitioned from operating general practice medical clinics (The Good Clinic, closed in Q4 2022 due to lack of profitability) to a holding company focused on data center services, cloud computing, application hosting (Centcore, LLC), and investment/acquisition in cloud/data center related applications, including AI-based software development (Vero Technology Ventures, LLC).
• A significant debt restructuring occurred in FY2024 and continued into FY2025, converting approximately $26.5 million of obligations (senior securities, notes, accounts payable) into 2,628,179 shares of restricted Common Stock (valued at $4.00/share) and 562,998 shares of Series A Amortizing Convertible Preferred Stock.
• As of October 31, 2025, the total value of outstanding Series A Preferred Stock is $14,666,850. These shares are subject to mandatory redemption over 36 months, starting January 1, 2025, either in cash (105% of original price) or common stock (10% discount to average of five lowest closing prices over 30 trading days).
• The company received $500,000 in initial funding from two Senior Secured 10% Original Issue Discount Convertible Promissory Notes (2025 Bridge Notes) issued on October 31, 2025, and December 22, 2025, convertible into common stock at $0.15 per share, with a potential total funding of $1 million.
• As of September 30, 2025, cash and cash equivalents were approximately $300, and current liabilities were approximately $17.6 million.
• For the nine months ended September 30, 2025, revenue was $38,700, and net income available to common shareholders was $116,984, primarily driven by a $3,513,655 gain on revaluation of derivative liabilities.
• For the twelve months ended December 31, 2024, revenue was $43,700, and net loss available to common shareholders was $2,842,256.
• The company faces substantial doubt about its ability to continue as a going concern due to recurring losses, negative cash flows, and the need for additional funding.
• The common stock trades on the OTC-QB Venture Market under the symbol MITI, with a closing price of $0.10 on December 26, 2025.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, including substantial doubt about its going concern ability, extremely low cash, and high liabilities. While there's a strategic pivot to new tech businesses and some debt restructuring, the immediate financial outlook and high dilution risk are overwhelmingly negative.

Positives

• Successful debt restructuring efforts converted approximately $26.5 million of obligations into equity, reducing immediate cash payment burdens.
• Formation of new business units, Centcore (data center services) and Vero Technology Ventures (cloud computing, AI applications), indicates a strategic pivot to potentially higher-growth sectors.
• Initial revenue generation of $38,700 for the nine months ended September 30, 2025, and $43,700 for the twelve months ended December 31, 2024, from the new Centcore subsidiary.
• Significant gain on revaluation of derivative liabilities of $3,513,655 for the nine months ended September 30, 2025, contributing to a temporary net income.
• Waiver of interest payments on Series F Preferred shares starting May 15, 2024, reducing accrued interest by over $200,000 per month.
• Recruitment of experienced professionals and contract programmers for the new business units, including an executive for Robo Agent development at $10,000 per month.
• Secured a contract in September 2025 for a new application related to sports and pickleball arena property listings, expected to be completed in late FY2026.

Negatives

• Substantial doubt about the company's ability to continue as a going concern due to recurring operating losses, negative cash flows, and limited financial resources.
• Extremely low cash and cash equivalents of approximately $300 as of September 30, 2025, and $55,000 as of November 13, 2025.
• High current liabilities of approximately $17.6 million as of September 30, 2025.
• Significant potential for dilution from the mandatory redemption of 97,779,013 Series A Preferred Stock shares into common stock, which could dilute existing shareholders by over 90%.
• The common stock is considered a 'penny stock' and is thinly traded, which may reduce liquidity and make it difficult for investors to sell shares.
• The stock price has been highly volatile, dropping from $0.60 on November 26, 2024, to $0.10 on December 26, 2025.
• Outstanding legal settlements totaling approximately $3.34 million from the closure of the clinic business, bearing interest at various rates.
• Identified material weaknesses in internal controls, including lack of segregation of duties and insufficient resources for financial reporting.
• The company has no full-time employees, relying on directors and consultants, which could pose operational risks.
• The new business plan has a limited operating history and may never become profitable.
• The company will not receive any proceeds from the current S-1 resale offering.

Risks

• Inability to raise additional capital to fund operations and execute the business plan.
• Evolving business model increases complexity and uncertainty.
• Data center co-location and software services operations present security, competition, and technological change risks.
• Heavy dependence on senior management; loss of key personnel could negatively impact stock price.
• Failure to anticipate and respond to rapid technological changes in the industry.
• Intense competition from larger, more resourced firms in the data services industry.
• Disruption or breach of security measures in data centers or cloud platforms could lead to reputational harm, legal exposure, and financial impact.
• Success is dependent on customer subscriptions and renewals, which are not guaranteed.
• Potential involvement in legal proceedings, with approximately $3.3 million in current outstanding obligations from clinic business settlements.
• Inability to effectively manage growth strategy, especially with potential acquisitions.
• Future acquisitions may result in dilutive equity issuances, increased indebtedness, and amortization expenses.
• Privacy concerns and evolving regulations (e.g., CCPA, CPRA, AI regulations) may limit service adoption and adversely affect the business.
• Industry-specific regulations and standards are evolving, and non-compliance could harm the business.
• Changes in statutes and regulations could negatively impact business practices.
• Acquisitions may subject the company to liabilities of sellers.
• Executive officers, directors, and certain key stockholders control a significant number of voting securities (over 50% as of Dec 31, 2024), potentially controlling stockholder voting outcomes.
• Sales of substantial amounts of shares (overhang) may adversely affect the share price.
• Common stock is a 'penny stock,' subject to SEC rules that may reduce liquidity.
• No intention to pay cash dividends in the near future; capital appreciation is the sole source of gain.
• Stock price has been volatile and thinly traded.
• Issuance of preferred stock without shareholder approval and other anti-takeover defenses could make acquisition more difficult and depress stock price.
• Cybersecurity threats, including ransomware, unauthorized access, and supply-chain attacks, could lead to significant financial losses, regulatory penalties, reputational harm, and operational disruptions.
• Challenges in detection and response to cybersecurity breaches.

Future Outlook

The company is a holding company seeking to provide products, services, and technology, with a focus on data center services, cloud computing, and AI applications through Centcore and Vero Technology Ventures. The initial AI-based application 'Robo Agent' is expected to be available for initial users in Q4 FY2025, with later versions targeting other B2C selling situations. A new application for sports and pickleball arena property listings is expected to be completed in late FY2026. The company expects to expand computing resources rapidly at minimal expense through co-location agreements and by developing smaller data centers in existing facilities.

Management Comments

• "We believe that this approach may allow us to expand capacity with minimal capital expenditure." (Regarding smaller format data centers)
• "We believe that the material weaknesses as reported will eventually be fully remediated, upon being properly capitalized to hire the proper personnel for segregation of duties and SEC and GAAP accounting knowledge." (Regarding internal control weaknesses)
• "We remain committed to the resolution of these outstanding items in a fair and timely manner." (Regarding outstanding obligations to Gardner)
• "It is anticipated that this approach will continue indefinitely as it does not desire to create the overhead associated with a large employment force." (Regarding reliance on consultants)

Industry Context

The company is pivoting into the highly competitive data services industry, including cloud computing and AI, which is characterized by rapid technological change. It faces competition from in-house IT departments, traditional global IT systems integrators (e.g., Accenture, IBM), cloud service providers (e.g., AWS, Microsoft Azure, Google Cloud Platform), regional managed services providers, and colocation providers (e.g., Equinix). The company aims to differentiate through its focus on cloud, technology expertise, customer experience, speed of innovation, and partner relationships. The AI market is also rapidly evolving, with new regulations being considered.

Comparison to Industry Standards

• The company is a new entrant in the data services industry, competing with established players like Accenture, Atos, Capgemini, Cognizant, Deloitte, DXC Technology, IBM (traditional IT integrators), AWS, Microsoft Azure, Google Cloud Platform (cloud service providers), and Equinix, CyrusOne, QTS (colocation providers).
• These competitors generally have greater name recognition, longer operating histories, significantly greater financial, technical, and marketing resources, larger global presence, and more established customer bases.
• The company's strategy of developing smaller format data centers with minimal capital expenditure and relying on consultants for staffing is a different approach compared to the large-scale operations of many established competitors.
• The company's focus on AI-based applications like "Robo Agent" for sales processes and a new application for sports/pickleball property listings targets niche markets within the broader cloud and AI industry.

Management Changes

Corporate Governance

Legal Proceedings

• Outstanding legal settlements from clinic business activities totaling $3,344,636 as of the filing date, including default judgments and settlement agreements with property owners.
• Settlement of Quincy Clinic matter on August 8, 2025, by providing an additional judgment of $500,000.
• Ongoing effort to negotiate settlement of remaining obligations to Gardner Builders Holdings, LLC (approximately $2.2 million).
• No claims received regarding administrative office lease in St. Louis Park, Minnesota, and the company believes no further obligation exists.

Related Party Transactions

• Acquisition of AgingTopic, LLC (source code and business activities) from Ms. Amy Lance, wife of CEO Mack Leath, for $5,000 cash payment and up to $150,000 in royalty payments.
• Michael C. Howe, former CEO of The Good Clinic, LLC, organized Leading Primary Care LLC, which acquired the remaining assets of The Good Clinic, LLC for approximately $2.5 million, cancelling existing notes payable and accrued interest owed to Mr. Howe. This was recognized as a contribution to capital.
• Mr. Howe also exchanged Series D and F Preferred Stock and accrued dividends/salary for Series F Preferred Stock.
• Mack Leath (CEO/CFO/Chairman) and Dr. Jordan Balencic (Director) received $60,000 per year stipend in Series X Preferred Stock and 250,000 shares of restricted common stock for services and performance in FY2024.
• Jim Clifton (Independent Director) received 75,000 shares of restricted stock for Advisory Board efforts and an additional 175,000 shares of restricted common stock and $60,000 of Series X Preferred stock for his Director role in FY2025, making his holdings equal to other directors.
• Anglo Irish Management LLC, managed by Daniel Hollis, holds 32,503 Series X Preferred shares (77.20% of Series X) and 273,495 common shares, representing 41.57% of total voting shares. These shares were issued for accounts payable and consulting fees, not open market purchases.
• Issuance of 20,000 shares of Series X Preferred Stock to an institutional investor and consultant (Anglo Irish Management LLC) for $500,000 in compensation in lieu of services during the nine months ended September 30, 2025.
• Settlement agreements with related parties (Finnegan, Lindstrom, M Diamond, Dobbertin, Mitchell, Leath, Naqvi) for notes payable and accrued interest, often involving issuance of common stock or Series A Preferred Stock, sometimes recorded as contributions to capital.

Stakeholder Impact

• Shareholders: Significant dilution risk from Series A Preferred Stock redemption and 2025 Bridge Notes conversion. Volatile and thinly traded stock, penny stock status. Potential for capital appreciation is the sole source of gain as no dividends are planned. Concentrated voting power with management and key shareholders.
• Creditors: Debt restructuring has converted many obligations into equity, but legal settlements from clinic closures still represent a significant liability. Ongoing negotiations with some vendors.
• Employees: No full-time employees; reliance on directors and consultants. This reduces overhead but may impact long-term stability and talent retention.
• Customers: New business units (Centcore, VTV) aim to provide data center and AI services, potentially offering new solutions but also facing intense competition.
• Management: Heavily dependent on senior management, with significant voting control.

Next Steps

• Continue development of the "Robo Agent" AI application, with initial users expected in Q4 FY2025.
• Complete the new application for sports and pickleball arena property listings by late FY2026.
• Expand computing resources through co-location agreements and development of smaller data centers.
• Remediate identified material weaknesses in internal controls by hiring proper personnel.
• Negotiate settlement of remaining obligations to vendors like Gardner Builders Holdings, LLC (approximately $2.2 million).
• Raise additional capital to sustain operations and execute the business plan.
• Continue monthly redemption of Series A Preferred Stock (1/36th of remaining amounts) in cash or common stock.

Key Dates

Recommendation

The company faces severe financial challenges, including substantial doubt about its ability to continue as a going concern, extremely low cash reserves, and significant current liabilities. While the strategic pivot to data center and AI services is a positive direction, the company has a limited operating history in these new ventures and has not yet demonstrated consistent profitability. The potential for over 90% dilution from preferred stock conversions, coupled with a highly volatile and thinly traded "penny stock" status, presents an exceptionally high risk for investors. The identified material weaknesses in internal controls further exacerbate concerns about financial stability and reporting reliability. Given these factors, the stock is highly speculative, and the risks far outweigh any potential upside at this stage.

Keywords

Data Center Services, Cloud Computing, AI Applications, Debt Restructuring, SEC S-1, Penny Stock, Going Concern, Corporate Governance, Preferred Stock, Common Stock, Dilution, Cybersecurity, Fintech, Real Estate Tech, Sports Tech